Predictive Oncology Stock Momentum Indicators Williams R percentage

POAI Stock  USD 0.80  0.05  6.67%   
Predictive Oncology momentum indicators tool provides the execution environment for running the Williams R percentage indicator and other technical functions against Predictive Oncology. Predictive Oncology value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Williams R percentage indicator function is designed to identify and follow existing trends. Momentum indicators of Predictive Oncology are pattern recognition functions that provide distinct formation on Predictive Oncology potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Williams %R value was developed by Larry Williams and ranges from zero to 100. The values are charted on an inverted scale. Values below 20 indicate an overbought condition for Predictive Oncology and a sell signal is generated when it crosses the 20 line. Values over 80 indicate an oversold condition for Predictive Oncology and a buy signal is generated when it crosses the 80 line.

Predictive Oncology Technical Analysis Modules

Most technical analysis of Predictive Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Predictive from various momentum indicators to cycle indicators. When you analyze Predictive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Predictive Oncology Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Predictive Oncology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Predictive Oncology based on widely used predictive technical indicators. In general, we focus on analyzing Predictive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Predictive Oncology's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Predictive Oncology's intrinsic value. In addition to deriving basic predictive indicators for Predictive Oncology, we also check how macroeconomic factors affect Predictive Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2024 (projected)
Payables Turnover0.480.540.31
Days Of Inventory On Hand290.55311.08387.01
Hype
Prediction
LowEstimatedHigh
0.040.806.63
Details
Intrinsic
Valuation
LowRealHigh
0.030.656.48
Details
Naive
Forecast
LowNextHigh
0.020.796.62
Details
1 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Predictive Oncology. Your research has to be compared to or analyzed against Predictive Oncology's peers to derive any actionable benefits. When done correctly, Predictive Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Predictive Oncology.

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Commodity Directory Now

   

Commodity Directory

Find actively traded commodities issued by global exchanges
All  Next Launch Module

Predictive Oncology pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Predictive Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will appreciate offsetting losses from the drop in the long position's value.

Predictive Oncology Pair Trading

Predictive Oncology Pair Trading Analysis

The ability to find closely correlated positions to Predictive Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Predictive Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Predictive Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Predictive Oncology to buy it.
The correlation of Predictive Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Predictive Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Predictive Oncology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Predictive Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Predictive Oncology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Predictive Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Predictive Oncology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Predictive Oncology Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Predictive Oncology. If investors know Predictive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Predictive Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.96)
Revenue Per Share
0.416
Quarterly Revenue Growth
(0.43)
Return On Assets
(0.56)
Return On Equity
(1.49)
The market value of Predictive Oncology is measured differently than its book value, which is the value of Predictive that is recorded on the company's balance sheet. Investors also form their own opinion of Predictive Oncology's value that differs from its market value or its book value, called intrinsic value, which is Predictive Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Predictive Oncology's market value can be influenced by many factors that don't directly affect Predictive Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Predictive Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Predictive Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Predictive Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.